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C36 Podium Presentations
Table 1
Prediction Parameter OR (95%CI) P value
Maximal Medial BML Grade 7.07 (2.80-17.84) <0.0001
Maximal Medial Meniscus Grade 1.08 (0.39-2.98) 0.88
WOMAC Pain 1.09 (0.97-1.23) 0.16
Valgus anatomic axis 0.20 (0.04-0.93) 0.04
Varus anatomic axis 1.52 (0.52-4.44) 0.44
(central medial femur) the denuded area appears to show the
highest univariate relation to purported predictive risk factors of
BML grade and meniscal morphology. For clinical trial planning
screening for maximal BML grade and excluding knees with
valgus alignment will afford the greatest opportunity to detect
progression.
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Purpose: There are signiﬁcant health care costs associated with
osteoarthritis (OA) of the knee due to several factors including
both utilization of health care services and loss of productivity. We
previously reported that traditional Chinese acupuncture (TCA)
given in a tapering schedule over 26 weeks was associated
with signiﬁcantly greater improvement in pain and function when
compared to both sham acupuncture and education alone (Ann
Intern Med 2004;141:901-10). Herein, we report results of a cost
effectiveness analysis of TCA in comparison to education alone
as adjunctive treatment for knee OA.
Methods: This analysis was limited to the 190 and 189 patients
randomized to the TCA and education alone groups, respectively;
data on patients randomized to sham acupuncture were not
used in this analysis. To estimate costs, we used self-reported
data from the Health Assessment Questionnaire (HAQ) that
was completed by participants at their 26 week close-out visit
to determine health care utilization including medication use,
hospitalizations, outpatient surgeries or procedures, emergency
room visits and doctor or health care worker visits. In addition,
we included the costs of providing the interventions. To measure
effectiveness, we estimated quality adjusted life years (QALYs)
gained, based on self-reported data from the EuroQoL (EQ-5D)
completed at baseline, 8- and 26 weeks. The changes in health
utility used to estimate gains in QALYs were calculated using
generalized estimating equations to account for the multiple
observations per study subject. Missing data were assumed to
be missing at random. We used 1000 bootstrapped repetitions
to describe the distribution of the cost-effectiveness results. In a
secondary analysis, we also estimated the costs per additional
OMERACT/OARSI responder.
Results: At 26 weeks, HAQ and EQ-5D data were available
on 131 (92.3%) of 142 and 91 (84.3%) of 108 subjects who
completed the entire study period in the TCA and education
alone groups, respectively. Participants in the TCA group used
fewer medications, had fewer hospitalizations (7.6% v 8.9%),
outpatient surgeries (13.0% v 16.5%), emergency room visits
(8.4% v 11.0%) and mean number of health care worker or
doctor visits (7.1% v 7.9%), but slightly higher mean number of
nights in hospital (0.61 v 0.58) than those in the education alone
group. Over the 26-week study period, the TCA group gained
0.06 QALYs when compared to education alone group.
The median cost-effectiveness was $32,000/QALY gained. The
cost-effectiveness acceptability curve shows that 95% of 1000
repetitions were consistent with a cost-effectiveness result of
less than $50,000/QALY gained (see Figure 1). As previously
reported, 52% of the TCA group and 30% of the education alone
group could be classiﬁed as OMERACT/OARSI responders. The
cost per additional responder achieved in the TCA group was
estimated as $30,000.
Figure 1
Conclusions: These analyses, based on data from a rigorous
26-week randomized controlled trial suggest that TCA is a cost
effective modality when used as an adjunctive therapy in patients
with symptomatic OA of the knee.
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CHONDROPROTECTIVEBY DISENGAGING
INFLAMMATION FROM DYSREGULATED
CHONDROCYTE DIFFERENTIATION AND FUNCTION
D.L. Cecil1, C.G. Appleton2, F. Beier2, R. Terkeltaub1
1UCSD/VAMC, San Diego, CA; 2University of Western Ontario,
London, ON, Canada
Purpose: In Osteoarthritis (OA), low-grade cartilage and joint
inﬂammation promotes dysregulated chondrocyte differentiation
and cartilage catabolism. Inﬂammatory and pro-catabolic signals
for human chondrocytes in OA are provided not only by traditional
cytokines such as IL-1, TNFalpha, and chemokines, but also by
moieties such as ﬁbronectin proteolytic fragments and the cal-
granulins S100A11 and S100A4. The calgranulins are ligands of
the patterning receptors RAGE (receptor for advanced glycation
endproducts) and CD36. S100A11, as well as TNFalpha and
CXCL8 (IL-8), induce RAGE signaling-dependent chondrocyte
hypertrophy. CD36 is a scavenger receptor whose ligands other
than calgranulins include thrombospondin and long-chain fatty
acids. PPARgamma agonists induce CD36 expression in cells
other than chondrocytes, and numerous studies have shown
PPARgamma activation to be anti-inﬂammatory. Furthermore,
the PPARgamma agonist, pioglitazone, reduces severity of ex-
perimental OA. Hence, we examined the expression and function
of CD36 in chondrocytes in vitro and in situ in experimental OA.
Methods: We employed an in vivo OA model using male
Sprague-Dawley rats that underwent joint destabilization surgery
by anterior cruciate ligament transection and partial medial
meniscectomy and forced mobilization of the joint. Since nor-
mal cultured chondrocytes did not express CD36, we transfected
CD36 to assess “gain of function” in human chondrocytes.
Results: We demonstrated that both RAGE and CD36 expres-
sion became increased by 4 weeks in vivo. RAGE expres-
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sion became uniformly increased in hypertrophic chondrocytes,
whereas CD36 expression developed most robustly at sites of
the most intense injury. We demonstrated that forced expres-
sion of CD36 blocked the capacity of S100A11, TNFalpha and
CXCL8 to induced chondrocyte hypertrophy. CD36 also blocked
the capacity of S100A11 to inhibit proteoglycans synthesis. Last,
the PPARgamma agonist N-(2-Benzoylphenyl)-O-[2-(methyl-2-
pyridinylamino)ethyl]-L-tyrosine hydrate induced CD36 expres-
sion without affecting RAGE expression in chondrocytes.
Conclusions: Early induction of CD36 expression by chon-
drocytes occurs at sites of cartilage injury as OA develops
experimentally. PPARgamma ligation, which is chondroprotec-
tive, induces chondrocyte CD36 expression in vitro. Chondrocyte
CD36 expression suppresses the capacity of not only its ligand
S100A11, but also of TNFalpha and CXCL8 to induce chon-
drocyte hypertrophy, and CD36 expression promotes preserva-
tion of proteoglycans synthesis. We conclude that chondrocyte
expression of CD36 is chondroprotective by disengaging re-
sponsiveness to inﬂammation from dysregulated chondrocyte
differentiation and function.
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THE “ALARMIN” S100 A8: AN ACTIVATOR OF
CHONDROCYTE MEDIATED CARTILAGE DAMAGE?
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Purpose: In a previous study we have shown that “alarmins”
S100A8 and S100A9 which can form dimers and are predomi-
nantly produced by myeloid cells in the synovial ﬂuid and synovial
membrane are involved in MMP-mediated cartilage destruction
during experimental arthritis. S100A8 forms the active part which
is stabilized by S100A9 and protects S100A8 from degradation.
As MMP mediated cartilage destruction is particularly found
around the chondrocyte this prompted us to investigate whether
S100A8 and A9 are produced by chondrocytes and whether
these “alarmins” are actively involved in MMP-mediated chon-
drocyte activation.
Methods: S100A8 and A9 proteins were detected in knee
joints of murine arthritis and osteoarthritis using immunolocal-
isation. Murine chondrocyte cell line H4 was stimulated with
pro-inﬂammatory cytokines (100 ng/ml) to investigate rS100A8
and A9 production or by recombinant S100A8 (0.2, 1 and 5
µg/ml) to investigate MMP and cytokine production.mRNA and
protein levels were measured using RT-PCR and blotanalysis.
S100A8/A9 dimers and cytokines were measured in culture su-
pernatant using ELISA and Luminex. Breakdown of aggrecan on
the pericellular surface of the chondrocyte was measured us-
ing VDIPEN and NITEGE (MMP and aggrecanase neoepitopes)
antibodies and FACS analysis.
Results: Immunolocalisation of inﬂamed knee joints depicted
that S100A8 and S100A9 proteins were abundantly expressed in
chondrocytes. Expression was particularly found in the superﬁcial
layers of the cartilage surfaces at the margins of the joint. Stim-
ulation of murine chondrocytes by pro-inﬂammatory cytokines
IL-17, IL-18 and IFNγ caused strong upregulation of particularly
S100A8 and in lesser extent S100A9 mRNA (S100A8: 24, 48
and 4 fold and S100A9: 4, 4 and 0 fold respectively). Stimulation
of chondrocytes by rS100A8 caused a signiﬁcant autoinduction
of S100A8 and in lesser extend upregulation of S100A9 mRNA
and protein levels. High concentrations of cytokines IL-6, KC and
RANTES were measured in the culture supernatant whereas
TNFα, IL-1α and β were below detection level. S100A8/A9 dimers
could not be detected by ELISA conﬁrming that S100A8 is the
active component and can directly activate chondrocytes. More-
over MMPs (-2,-3,-9,-13) and ADAMTS(-4,-5) mRNA levels in
the chondrocyte were strongly upregulated (maximal at 1 µg/ml
(4, 4, 3, 16, 8 and 4 times respectively). VDIPEN and NITEGE
neoepitopes on the pericellular membrane of chondrocytes were
signiﬁcantly elevated after stimulation with rS100A8 for 24 hours
in a concentration (0,2, 1 and 5 µg/ml) dependent manner.
(VDIPEN 17,67,108% and NITEGE 8, 33 and 67% respectively).
Conclusions: The alarmin S100A8 is produced by chondro-
cytes and directly activates MMP and aggrecanase mediated
peri-cellular matrix degradation. S100A8 may be an important
mediator of severe cartilage destruction.
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INTERLUKIN-7 STIMULATES SECRETION OF S100A4 BY
ACTIVATING THE JAK-STAT PATHWAY IN HUMAN
ARTICULAR CHONDROCYTES
R.R. Yammani, D. Long, R. Loeser
Wake Forest University School of Medicine, Winston-Salem, NC
Purpose: S100A4, a member of the S100 family of calcium bind-
ing proteins, has been shown to be increased in OA cartilage and
to stimulate chondrocyte RAGE signaling resulting in increased
expression of MMP-13. Members of S100 family are known to be
secreted into the extra-cellular environment, however the mech-
anism(s) of secretion is not completely understood. The aim of
this study was to determine the pathway involved in secretion of
S100A4 in response to cytokines in chondrocytes.
Methods: Human articular chondrocytes isolated from normal
ankle cartilage obtained from tissue donors were cultured in
high density monolayers in media with 10% serum for 5-7 days.
Conﬂuent monolayers were then changed to serum free media
16-18hr prior to treatment with 10ng/ml of IL-7, IL-1β and TNF
α. In some experiments, cells were pre-treated with a JAK-3
inhibitor or Brefeldin-A (BFA), a chemical inhibitor that blocks
classical protein translocation. Immuno-blotting with phospho-
speciﬁc antibodies was used to determine the activation of
signaling proteins. Secretion of S100A4 was measured in the
conditioned media by immuno-blotting with polyclonal antibodies
to S100A4.
Results: Chondrocyte secretion of S100A4 was observed af-
ter treatment with IL-7 and TNFα but not with IL-1β. Treatment
with IL-7 resulted in activation of the JAK/STAT pathway with
increased phosphorylation of JAK-3 and STAT-3. IL-7 stimulation
of S100A4 secretion was inhibited by pretreatment with a JAK-3
inhibitor. In addition, pretreatment with Brefeldin-A (BFA) didn’t
effect the secretion of S100A4 suggesting a pathway indepen-
dent of Golgi-endoplasmic reticulum (classical pathway).
Conclusions: Our study demonstrates for the ﬁrst time that IL-7
or TNFα but not IL-1β can stimulate chondrocyte secretion of
S100A4 via activation of JAK/STAT signaling. We have recently
found that OA chondrocytes produce IL-7 and others have shown
TNFα. These cytokines may contribute to cartilage destruction
through secretion of S100A4 which can function as an autocrine
factor to stimulate MMP-13 production via RAGE.
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Purpose: Synovial inﬂammation in osteoarthritis (OA) patients
has been associated with increased pain, disability, and more
